The association between metabolic syndrome and its components and heart failure in patients referred to a primary care facility;Associação da síndrome metabólica e seus componentes na insuficiência cardíaca encaminhada da atenção primária

Arquivos Brasileiros de Cardiologia

Volumn 89, Issue 1, 2007, Pages

  Coelho, Flávio Augusto Colucci ^a,b   Moutinho, Marco Aurélio Espósito ^a   De Miranda, Verônica Alcooforado ^a   Tavares, Leandro Reis ^a   Rachid, Maurício ^a   Rosa, Maria Luiza Garcia ^a   Mesquita, Evandro Tinoco ^a  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiac output, low; Heart failure; Metabolic syndrome; Primary health care; Women

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATIENT REFERRAL; PREVALENCE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; SEX RATIO; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLE; SYSTOLIC DYSFUNCTION; TIME SERIES ANALYSIS; BLOOD; BLOOD PRESSURE; BRAZIL; ECHOGRAPHY; EPIDEMIOLOGY; HEART VENTRICLE; HEART VENTRICLE FUNCTION; MIDDLE AGED; PHYSIOLOGY; PRIMARY HEALTH CARE; REFERENCE VALUE; SEX DIFFERENCE;

BLOOD PRESSURE; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIMARY HEALTH CARE; REFERENCE VALUES; SEX FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION;

EID: 34548726875     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lakka HM, Laaksonnen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilento J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288 (21): 2709-16.
2. Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002; 4: 448-53.
3. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002; 162: 1867-72.
4. Ingelsson E, Ärnlöv J, Lind L, Sundström J. Metabolic syndrome and risk for heart failure in middle-aged men. Heart. 2006; 92: 1409-13.
5. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21: 1414-31.
6. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002; 287: 356-9.
7. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-53.
8. National Cholesterol Education Program: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97.
9. I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol. 2005; 84 (supl 1): 3-28.
10. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993; 22: 6A-13A.
11. Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, et al., on behalf of the EPICA Investigators. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002; 4: 531-9.
12. Leiro MGC, Martín MJP. Insuficiencia cardiaca. ¿Son diferentes las mujeres? Rev Esp Cardiol. 2006; 59: 725-35.
13. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol. 2003; 42 (12): 2128-34.
14. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, et al., Health ABC Study. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol. 2006; 47 (8): 1595-602.
15. Holmang A, Yoshida N, Jennische E, Waldenstrom A, Bjorntorp P. The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats. Eur J Clin Invest. 1996; 26: 973-8.
16. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinaemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991; 87 (6): 2246-52.
17. Wong CY, O'Moore-Sullivan T, Fang ZY, Haluska B, Leano R, Marwick TH. Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol. 2005; 96 (12): 1686-91.
18. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-49.
19. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005; 112: 1756-62.
20. Ingelsson E, Risérus NEF, Berne C, Frystyk JM, Flyberg A, Alexander T, et al. Adiponectin and risk of congestive heart failure. JAMA. 2006; 295 (15): 1772-4.
21. Gustafsson F, Torp-Pedersen C, Burchardt H, Buch P, Seibaek M, Kjoller E, et al. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J. 2004; 25: 129-35.
22. Rodríguez-Artalejo F, Banegas Banegas J, Guallar-Castillón P. Epidemiología de la insuficiencia cardiaca. Rev Esp Cardiol. 2004; 57: 163-70.
23. Kenchaiah S, Evans J, Levy D, Wilson P, Benjamin E, Larson M, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347: 305-13.
24. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002; 53: 672-7.
25. Levy D, Kenchaiah S, Larson M, Benjamin E, Kupka M, Ho K, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347: 1397-402.
26. Barker W, Mullooly J, Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation. 2006; 113: 799-805.
27. Levy D, Larson M, Vasan R, Kannel W, Ho K. The progression from hypertension to congestive heart failure. JAMA. 1996; 275: 1557-62.
28. Grundy SM. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov. 2006; 5 (4): 295-309.
29. Rutter M, Parise H, Benjamin E, Levy D, Larson M, Meigs J, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003; 107: 448-54.
30. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JAM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005; 111 (5): 583-90.
31. Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS. Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care. 2003; 26 (11): 2983-9.
32. Cleland JGF, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail. 2006; 8 (1): 105-10.
33. Van der Harst P, Voors AA, Van Gilst WH, Böhm M, Van Veldhuisen DJ. Statins in the treatment of chronic heart failure: biological and clinical considerations. Cardiovasc Res. 2006; 71 (3): 443-54.
34. Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation. 2003; 108: 839-43.
35. Laufs U, Wassmann S, Schackmann S, Heeschen C, Bohm M, Nickenig G. Beneficial effects of statins in patients with non-ischemic heart failure. Z Kardiol. 2004; 93: 103-8.
36. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005; 352: 1425-35.